Genotype-controlled analysis of serum dopamine beta-hydroxylase activity in civilian Post-traumatic Stress Disorder.
Sunday, July 18th, 2010BACKGROUND: Norepinephrine (NE) plays a central role in post-traumatic stress disorder (PTSD). Dopamine beta-hydroxylase (DbetaH) converts dopamine (DA) to NE and its activity varies widely across individuals. Mustapic et al. (2007) reported a PTSD-associated deficit in serum DbetaH activity (sDbetaH) in a genotype-controlled analysis of combat veterans. We tested whether such a deficit would occur in a sample of civilians. METHODS: The severity of current adult PTSD symptoms and current DSM-IV diagnosis of PTSD were determined by the PTSD Symptom Scale (PSS). Adulthood trauma exposure was assessed using the Traumatic Experience Inventory (TEI). sDbetaH was assayed by HPLC with electrochemical detection and genotypes were determined using the Taqman(R) platform. RESULTS: Two hundred and twenty seven African American (AA) subjects were enrolled in this study, with a mean age (+/- SD) of 42.9 (+/-12.9) years. We found a strong association between rs1611115 genotype and sDbetaH (p<0.0001). After controlling for adulthood trauma exposure, there were no significant differences of sDbetaH between subjects who met a PTSD diagnosis and those who did not (p>0.05) in any genotype group. No significant correlations were found between sDbetaH and PTSD severity, but sDbetaH significantly associated with the status of comorbid depression based on the cutoff of HAMD (p=0.014) in subjects with PTSD. CONCLUSIONS: We have replicated in this sample the prior finding that DBH rs1611115 genotype strongly associates with sDbetaH. No associations between sDbetaH and PTSD diagnosis or symptom severity in this civilian sample. Copyright © 2010. Published by Elsevier Inc.
Tags: Dopaminergic Medicine